Rik Rozemeijer

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Rik Rozemeijer, Mèra Stein, Michiel Voskuil et al. · Circulation · 2018 · 39 citations

Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation

Masieh Abawi, Rik Rozemeijer, Piergiuseppe Agostoni et al. · Netherlands Heart Journal · 2017 · 30 citations · Full text

3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent

Nicole D. van Hemert, Michiel Voskuil, Rik Rozemeijer et al. · JACC: Cardiovascular Interventions · 2021 · 17 citations

3-Year Clinical Outcomes, Vascular Surgery, Lumen-apposing Metal Stent +5

Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients

Rik Rozemeijer, CP Wong, Geert E. Leenders et al. · Netherlands Heart Journal · 2019 · 16 citations · Full text

Rationale and design of amphilimus sirolimus‐eluting stents versus zotarolimus‐eluting stents in all‐comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial

Rik Rozemeijer, Mèra Stein, Peter Frambach et al. · Catheterization and Cardiovascular Interventions · 2017 · 10 citations